Table 3.
Secondary continuous outcome results in intention to treat population
| Time point | Cast | K-wire | Mean difference | P value | |||||
|---|---|---|---|---|---|---|---|---|---|
| No | Mean (SD) | No | Mean (SD) | Unadjusted | Adjusted (95% CI) | ||||
| EQ-5D-5L index | |||||||||
| Baseline (post-injury) | 252 | 0.35 (0.28) | 241 | 0.37 (0.26) | 0.02 | - | - | ||
| 3 months | 217 | 0.68 (0.21) | 203 | 0.67 (0.20) | −0.01 | −0.02 (−0.06 to 0.02) | 0.37 | ||
| 6 months | 204 | 0.75 (0.21) | 207 | 0.75 (0.18) | 0.00 | 0.00 (−0.04 to 0.04) | 0.96 | ||
| 12 months | 199 | 0.81 (0.20) | 197 | 0.78 (0.21) | −0.02 | −0.03 (−0.07 to 0.02) | 0.26 | ||
| Area under curve over 12 months | - | 0.69* | - | 0.68* | - | −0.01 (−0.05 to 0.03) | 0.82 | ||
| EQ-VAS | |||||||||
| Baseline (post-injury) | 253 | 63.87 (22.76) | 242 | 64.19 (23.14) | 0.32 | - | |||
| 3 months | 216 | 77.08 (18.25) | 201 | 75.55 (18.51) | −1.53 | −1.73 (−5.44 to 1.98) | 0.36 | ||
| 6 months | 202 | 79.29 (20.02) | 204 | 81.09 (16.37) | 1.80 | 1.87 (−1.88 to 5.61) | 0.33 | ||
| 12 months | 199 | 81.11 (18.06) | 195 | 80.42 (18.00) | −0.69 | −0.51 (−4.30 to 3.29) | 0.79 | ||
| Area under curve over 12 months | 76.81* | - | 76.98* | - | 0.16 (−3.59 to 3.92) | 0.97 | |||
EQ-5D-5L=EuroQol five dimension five level scale; EQ-VAS=EuroQol Visual Analogue Scale.
*
Model estimate. Analysis based on mixed effects model with repeated measures from all time points.